We’re excited to feature an engaging session by Martin Blume (Robert Koch Institute, Germany)
Talk: Metabolic vulnerabilities of bradyzoites
This session highlights how targeting the unique metabolic dependencies of chronic-stage bradyzoites could open new therapeutic avenues to eliminate latent toxoplasmosis, a critical step toward addressing persistent infection.
This conference is organized by Impact Research Communications (IRC)
🔗 More info: https://toxoplasma.ircconferences.net/ | Advances in Toxoplasmosis Research
